Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence: Significance of Pathologic Nodal Status After Neoadjuvant Chemotherapy

Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence:... Ann Surg Oncol (2018) 25:2127–2128 https://doi.org/10.1245/s10434-018-6544-0 ED ITORIA L – G A STROI N TESTIN A L O NCOL OG Y Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence: Significance of Pathologic Nodal Status After Neoadjuvant Chemotherapy Takushi Yasuda, MD Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka , Japan The main goals of neoadjuvant therapy are to increase A review of the role and position of chemotherapy in the curative resection rate by downstaging the primary multimodality therapy would be timely. The findings of tumor and to improve postoperative survival by eliminating several randomized clinical studies comparing neoadjuvant systemic micrometastases. Chemoradiotherapy (CRT), the CRT and NAC are currently under way and will provide mainstay of preoperative therapy for advanced esophageal some guidance in this regard. cancer in Western countries, has dramatically improved Chemotherapy is the only treatment method that can be local control by increasing the R0 resection rate. However, used to control the systemic spread of esophageal cancer. distant metastasis is common, and two recent randomized However, systemic micrometastases cannot always be clinical studies comparing neoadjuvant CRT and neoadju- eliminated by two or three courses of NAC, and vant chemotherapy (NAC) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence: Significance of Pathologic Nodal Status After Neoadjuvant Chemotherapy

Loading next page...
 
/lp/springer_journal/future-treatment-strategy-for-esophageal-cancer-based-on-prediction-of-DyTjPeYwbZ
Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-018-6544-0
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:2127–2128 https://doi.org/10.1245/s10434-018-6544-0 ED ITORIA L – G A STROI N TESTIN A L O NCOL OG Y Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence: Significance of Pathologic Nodal Status After Neoadjuvant Chemotherapy Takushi Yasuda, MD Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka , Japan The main goals of neoadjuvant therapy are to increase A review of the role and position of chemotherapy in the curative resection rate by downstaging the primary multimodality therapy would be timely. The findings of tumor and to improve postoperative survival by eliminating several randomized clinical studies comparing neoadjuvant systemic micrometastases. Chemoradiotherapy (CRT), the CRT and NAC are currently under way and will provide mainstay of preoperative therapy for advanced esophageal some guidance in this regard. cancer in Western countries, has dramatically improved Chemotherapy is the only treatment method that can be local control by increasing the R0 resection rate. However, used to control the systemic spread of esophageal cancer. distant metastasis is common, and two recent randomized However, systemic micrometastases cannot always be clinical studies comparing neoadjuvant CRT and neoadju- eliminated by two or three courses of NAC, and vant chemotherapy (NAC)

Journal

Annals of Surgical OncologySpringer Journals

Published: May 29, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off